终末期肾病的流行病学：1980 - 1985年洛杉矶中南部地区的六年经验
The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85.
作者信息
Ferguson R, Grim C E, Opgenorth T J
出版信息
Am J Public Health. 1987 Jul;77(7):864-5. doi: 10.2105/ajph.77.7.864.
Abstract
Using the End-Stage Renal Disease Medical Information System and 1980 census information, the crude cumulative incidence among Blacks, Hispanics, and Whites in south central Los Angeles was determined to be 160.1, 49.28, and 55.3 per 100,000 respectively. Sex-specific rates were slightly greater in males. Among Blacks, nephrosclerosis and diabetes represented 41.5 and 30.2 per cent of the cases respectively and increased during the period 1980-85.
摘要
利用终末期肾病医疗信息系统和1980年人口普查信息，确定洛杉矶中南部黑人、西班牙裔和白人的粗累积发病率分别为每10万人160.1、49.28和55.3。男性的性别特异性发病率略高。在黑人中，肾硬化症和糖尿病分别占病例的41.5%和30.2%，并且在1980年至1985年期间有所增加。
相似文献
1
The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85.终末期肾病的流行病学：1980 - 1985年洛杉矶中南部地区的六年经验
Am J Public Health. 1987 Jul;77(7):864-5. doi: 10.2105/ajph.77.7.864.
2
Excess incidence of treatment of end-stage renal disease in Mexican Americans.墨西哥裔美国人终末期肾病治疗的超额发病率。
Am J Epidemiol. 1988 Jan;127(1):135-44. doi: 10.1093/oxfordjournals.aje.a114773.
3
Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States).前列腺癌：美国加利福尼亚州洛杉矶县不同种族/族裔群体的死亡率和特定阶段发病率趋势
Cancer Causes Control. 1995 Nov;6(6):492-8. doi: 10.1007/BF00054156.
4
Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system.在一个综合医疗体系中，估算肾小球滤过率下降、终末期肾病和死亡率的种族差异。
Am J Kidney Dis. 2013 Aug;62(2):236-44. doi: 10.1053/j.ajkd.2013.01.019. Epub 2013 Mar 15.
5
Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project.血液透析患者选定中间结局的种族/族裔分析：1997年终末期肾病核心指标项目的结果
Am J Kidney Dis. 1999 Oct;34(4):721-30. doi: 10.1016/s0272-6386(99)70399-9.
6
Sustained Lower Incidence of Diabetes-Related End-Stage Kidney Disease Among American Indians and Alaska Natives, Blacks, and Hispanics in the U.S., 2000-2016.2000-2016 年期间，美国的美国印第安人和阿拉斯加原住民、黑人和西班牙裔人群中与糖尿病相关的终末期肾病发病率持续下降。
Diabetes Care. 2020 Sep;43(9):2090-2097. doi: 10.2337/dc20-0495. Epub 2020 Jul 2.
7
Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of california cancer registry data, 1988-93.1988 - 1993年加利福尼亚癌症登记数据中，非西班牙裔白人、西班牙裔、亚裔和黑人皮肤黑色素瘤的发病率分析
Cancer Causes Control. 1997 Mar;8(2):246-52. doi: 10.1023/a:1018432632528.
8
Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.糖尿病终末期肾病发病率在种族和糖尿病类型方面的差异。
N Engl J Med. 1989 Oct 19;321(16):1074-9. doi: 10.1056/NEJM198910193211603.
9
Third-World Hodgkin's disease at Los Angeles County-University of Southern California Medical Center.
J Clin Oncol. 1988 Aug;6(8):1285-92. doi: 10.1200/JCO.1988.6.8.1285.
10
Racial differences in the incidence of end-stage renal disease.终末期肾病发病率的种族差异。
Ethn Health. 1996 Mar;1(1):21-31. doi: 10.1080/13557858.1996.9961767.
引用本文的文献
1
Financial Toxicity and Kidney Disease in Children and Adults: A Scoping Review.儿童和成人的经济毒性与肾脏疾病：一项范围综述
Int J Nephrol Renovasc Dis. 2025 Jan 21;18:13-25. doi: 10.2147/IJNRD.S485111. eCollection 2025.
2
Interventions to support decision-making, health literacy and self-management in ethnic-minority adults living with chronic kidney disease: a systematic review.支持患有慢性肾病的少数民族成年人进行决策、健康素养提升和自我管理的干预措施：一项系统综述
Clin Kidney J. 2023 Mar 10;16(6):914-927. doi: 10.1093/ckj/sfac276. eCollection 2023 Jun.
3
Evidence of selection as a cause for racial disparities in fibroproliferative disease.选择作为纤维增生性疾病种族差异原因的证据。
PLoS One. 2017 Aug 8;12(8):e0182791. doi: 10.1371/journal.pone.0182791. eCollection 2017.
4
Pleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative Diseases.免疫反应的多效性效应解释了纤维增生性疾病患病率的差异。
PLoS Genet. 2015 Nov 5;11(11):e1005568. doi: 10.1371/journal.pgen.1005568. eCollection 2015 Nov.
5
Association between circulating specific leukocyte types and incident chronic kidney disease: the Atherosclerosis Risk in Communities (ARIC) study.循环中特定白细胞类型与慢性肾脏病发病之间的关联：社区动脉粥样硬化风险（ARIC）研究
J Am Soc Hypertens. 2012 Mar-Apr;6(2):100-8. doi: 10.1016/j.jash.2011.10.001. Epub 2011 Nov 3.
6
End-stage renal disease in Taiwan: a case-control study.台湾地区终末期肾病：一项病例对照研究。
J Epidemiol. 2009;19(4):169-76. doi: 10.2188/jea.je20080099. Epub 2009 Jun 20.
7
Race and kidney disease: the scope of the problem.种族与肾脏疾病：问题的范围
J Natl Med Assoc. 2002 Aug;94(8 Suppl):1S-6S.
8
Treatment of hypertension in the presence of coexisting medical conditions.合并其他疾病时高血压的治疗。
Drugs Aging. 1994 Apr;4(4):304-12. doi: 10.2165/00002512-199404040-00003.
9
Renal failure among male Hispanics in the United States.美国男性西班牙裔中的肾衰竭
Am J Public Health. 1995 Jul;85(7):1001-4. doi: 10.2105/ajph.85.7.1001.
10
End state renal disease among Native Americans, 1983-86.1983 - 1986年美国原住民中的终末期肾病
Am J Public Health. 1990 Mar;80(3):318-9. doi: 10.2105/ajph.80.3.318.
本文引用的文献
1
Race and end-stage renal disease.
N Engl J Med. 1982 May 27;306(21):1290-1. doi: 10.1056/NEJM198205273062109.
2
Racial differences in the incidence of treatment for end-stage renal disease.终末期肾病治疗发生率的种族差异。
N Engl J Med. 1982 May 27;306(21):1276-9. doi: 10.1056/NEJM198205273062106.
3
The incidence of treated end stage renal disease in the eastern United States: 1973-1979.美国东部地区经治疗的终末期肾病发病率：1973 - 1979年
Am J Public Health. 1984 Jan;74(1):14-7. doi: 10.2105/ajph.74.1.14.
4
Racial factors in the incidence and causation of end-stage renal disease (ESRD).终末期肾病（ESRD）发病率及病因中的种族因素。
Trans Am Soc Artif Intern Organs. 1977;23:28-33. doi: 10.1097/00002480-197700230-00008.
5
Demographic analysis: end-stage renal disease and its treatment in the United States.人口统计学分析：美国的终末期肾病及其治疗
Clin Nephrol. 1979 Feb;11(2):47-51.
6
An areawide survey of treated end-stage renal disease.经治疗的终末期肾病的全区域调查。
Am J Public Health. 1978 Feb;68(2):166-9. doi: 10.2105/ajph.68.2.166.
Zotero 插件